|
Aug 27
|
Axsome Therapeutics to Participate in Investor Conferences in September
|
|
Jul 30
|
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
|
Jul 23
|
7 Biotech Stocks to Keep on Your Clinical Radar
|
|
Jun 19
|
Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week
|
|
May 13
|
15 Most Depressed States in the US
|
|
May 11
|
Prediction: These 2 Growth Stocks Could Triple By 2030
|
|
May 9
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
Jan 2
|
2 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Jan 2
|
Investing in Axsome Therapeutics (NASDAQ:AXSM) five years ago would have delivered you a 796% gain
|
|
Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
|
Dec 10
|
3 Unstoppable Stocks to Buy Right Now
|
|
Dec 7
|
Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today
|
|
Oct 24
|
Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer’s Disease Agitation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Conference
|
|
Oct 23
|
3 No-Brainer Stocks to Buy Right Now for Less than $100
|
|
Sep 21
|
Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day
|
|
Sep 19
|
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Earnings Haven't Escaped The Attention Of Investors
|
|
Sep 7
|
Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
|
|
Sep 5
|
Axsome Therapeutics to Present at Three Upcoming Investor Conferences
|
|
Jul 13
|
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
|